Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF and 1% metformin gel for periodontal intrabony defects
IRCT20100427003813N6Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules, Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metformin and autologous platelet-rich plasma in chronic periodontitis (4 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Vertical clinical attachment level, Gingival index and 2 more. Started Apr 2017; status: completed.
02
Drugs
metforminautologous platelet-rich plasma
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on IRCT20100427003813N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100427003813N6.